Meet SCARLETRED at the 3rd Dermatology Drug Development Europe Summit
DE
EN

Meet SCARLETRED at the 3rd Dermatology Drug Development Europe Summit

Author

Following a successful launch in Europe in 2019, and a tremendous online experience in 2021, the 3rd Dermatology Drug Development Europe Summit, returns in April 2022 in Frankfurt, Germany.

Therapeutic innovation in the dermatology space is growing at an exponential rate, propelling an increase in the awareness and knowledge of inflammatory skin conditions’ pathophysiology. The summit will tackle issues and focus on the optimization of novel strategies to accelerate the development and commercialization of dermatological treatments for chronic inflammatory and autoimmune skin conditions.

The summit will cover various topics, the including regulatory perspective of the current dermatology drug development landscape, discovery, pre-clinical development and translational research, clinical development and research as well as market access, reimbursement and commercial decision making.

We are delighted to say that SCARLETRED will be joining as an innovation partner and as part of the summit, our CEO, Dr. Harald Schnidar, will be among the great speakers giving insights into “Artificial Intelligence Supported Mobile Skin Imaging & Objective Digital Analysis of Drug Effects in Clinical Trials & Post-Marketing”.

Visit the official homepage of the 3rd Annual Dermatology Drug Development Europe Summit to explore more about the event.

Keywords:Certified, CE class 1m medical device, ISO13485
Download PDF

Like the article? Spread the word

linkedin-icon

Related Events

Events

3rd Dermatology Drug Development Europe Summit

April 5, 2022
Frankfurt, Germany

SCARLETRED will be presenting about the topic “Artificial Intelligence Supported Mobile Skin Imaging & Objective Digital Analysis of Drug Effects in Clinical Trials & Post-Marketing” at the summit.

Find out more